...
首页> 外文期刊>The cancer journal >New Developments in Interventional Oncology Liver Metastases From Colorectal Cancer
【24h】

New Developments in Interventional Oncology Liver Metastases From Colorectal Cancer

机译:大肠癌介入性肿瘤肝转移的新进展

获取原文
获取原文并翻译 | 示例
           

摘要

Colorectal cancer is the third leading cause of cancer death in the United States. Although hepatic excision is the first-line treatment for colorectal liver metastasis (CRLM), few patients are candidates. Locoregional therapy (LRT) encompasses minimally invasive techniques practiced by interventional radiology. These include ablative treatments (radiofrequency ablation, microwave ablation, and cryosurgical ablation) and transcatheter intra-arterial therapy (hepatic arterial infusion chemotherapy, transarterial "bland" embolization, transarterial chemoembolization, and radioembolization with yttrium 90). The National Comprehensive Cancer Network recommends LRT for unresectable CRLM refractory to chemotherapy. The following is a review of LRT in CRLM, including salient features, advantages, limitations, current roles, and future considerations.
机译:结直肠癌是美国癌症死亡的第三大主要原因。尽管肝切除术是结直肠肝转移(CRLM)的一线治疗方法,但很少有患者可以入选。局部区域疗法(LRT)包括介入放射学实践的微创技术。这些措施包括消融治疗(射频消融,微波消融和冷冻外科消融)和经导管动脉内治疗(肝动脉灌注化疗,经动脉的“温和”栓塞,经动脉化学栓塞和使用钇90进行放射栓塞)。国家综合癌症网络推荐LRT用于不可切除的CRLM,难治性化疗。以下是CRLM中的LRT的回顾,包括主要功能,优势,局限性,当前角色和未来考虑因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号